{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:57:58Z","timestamp":1793059078363,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.clindermatol.2026.08.005","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:34:53Z","timestamp":1786322093000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Glucagon-like peptide-1 receptor agonists and related incretin therapies in dermatology: Patient selection and shared decision-making"],"prefix":"10.1016","author":[{"given":"Somto","family":"Ndubisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7600-0152","authenticated-orcid":false,"given":"Peter","family":"Lio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2026.08.005_bib0001","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1001\/jama.2024.18219","article-title":"GLP-1 medication use for type 2 diabetes has soared","volume":"332","author":"Hegland","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.clindermatol.2026.08.005_bib0002","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2026.08.005_bib0003","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2026.08.005_bib0004","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/09546634.2016.1187707","article-title":"Characterization of obesity rates for dermatologic ambulatory office visits to United States physicians","volume":"28","author":"Jr","year":"2017","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2026.08.005_bib0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jdin.2025.12.008","article-title":"GLP-1 receptor agonist use in patients with psoriasis or hidradenitis suppurativa","volume":"25","author":"Granovsky","year":"2025","journal-title":"JAAD Int"},{"key":"10.1016\/j.clindermatol.2026.08.005_bib0006","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s11606-012-2077-6","article-title":"Shared decision making: a model for clinical practice","volume":"27","author":"Elwyn","year":"2012","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.clindermatol.2026.08.005_bib0007","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e256","article-title":"Shared decision making: really putting patients at the centre of healthcare","volume":"344","author":"Stiggelbout","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.clindermatol.2026.08.005_bib0008","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jaad.2018.12.070","article-title":"Skin changes in the obese patient","volume":"81","author":"Hirt","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2026.08.005_bib0009","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/jamadermatol.2026.1753","article-title":"Ixekizumab with or without tirzepatide in adults with psoriasis and overweight or obesity: a phase 3b randomized clinical trial","volume":"162","author":"Lebwohl","year":"2026","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2026.08.005_bib0010","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/jdv.70247","article-title":"Impact of weight-loss interventions on psoriasis severity: a systematic review and meta-analysis","volume":"40","author":"Morrow","year":"2026","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2026.08.005_bib0011","first-page":"143","article-title":"Impact of GLP-1 receptor agonists on psoriasis and cardiovascular comorbidities: a narrative review","volume":"14","author":"Haran","year":"2024","journal-title":"Psoriasis (Auckl)"},{"key":"10.1016\/j.clindermatol.2026.08.005_bib0012","unstructured":"Gouvrion L, Delage M, Villani AP, et al. Glucagon-like peptide-1 receptor agonists in hidradenitis suppurativa. JAMA Dermatol. in press."},{"key":"10.1016\/j.clindermatol.2026.08.005_bib0013","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.jaad.2025.06.077","article-title":"Glucagon-like peptide-1 receptor agonists in the adjunctive treatment of patients with hidradenitis suppurativa: a systematic review","volume":"93","author":"S\u00e1nchez-Feliciano","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2026.08.005_bib0014","doi-asserted-by":"crossref","DOI":"10.1007\/s40257-026-01049-8","article-title":"A systematic review of the clinical impact of GLP-1 receptor agonists in hidradenitis suppurativa","author":"Visan","year":"2026","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2026.08.005_bib0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamadermatol.2026.1907","article-title":"GLP-1 receptor agonist use and clinical outcomes in patients with hidradenitis suppurativa","author":"Jastrzab-Miskiewicz","year":"2026","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2026.08.005_bib0016","doi-asserted-by":"crossref","DOI":"10.1093\/asjof\/ojaf056","article-title":"Ozempic Face\u201d in plastic surgery: a systematic review of the literature on GLP-1 receptor agonist mediated weight loss and analysis of public perceptions","volume":"7","author":"Daneshgaran","year":"2025","journal-title":"Aesthet Surg J Open Forum"},{"key":"10.1016\/j.clindermatol.2026.08.005_bib0017","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/ohn.1209","article-title":"Radiographic midfacial volume changes in patients on GLP-1 agonists","volume":"173","author":"Sharma","year":"2025","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.clindermatol.2026.08.005_bib0018","doi-asserted-by":"crossref","first-page":"NP809","DOI":"10.1093\/asj\/sjae132","article-title":"Decoding the implications of glucagon-like peptide-1 receptor agonists on accelerated facial and skin aging","volume":"44","author":"Ridha","year":"2024","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.clindermatol.2026.08.005_bib0019","article-title":"Alopecia as an emerging adverse effect associated with glucagon-like peptide-1 (GLP-1) receptor agonists for weight loss: a scoping review","volume":"17","author":"Rojas Lopez","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.clindermatol.2026.08.005_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1043789","article-title":"Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: a real-world disproportionality study based on FDA adverse event reporting system database","volume":"13","author":"Liu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X26002154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X26002154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T06:36:48Z","timestamp":1788676608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X26002154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":20,"alternative-id":["S0738081X26002154"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2026.08.005","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucagon-like peptide-1 receptor agonists and related incretin therapies in dermatology: Patient selection and shared decision-making","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2026.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}